Over the years, several of us fretted that NNVC's management team, while good at developing novel and potentially disruptive anti-virals, lacked the business skills and marketplace acumen to successfully carry a product to market. I now confess to being totally wrong. When Diwan and Seymour became certain of the commercial viability of their discovery, they went out and hired all the expertise they needed to bring it to market. And, they did it without overburdening their financial structure. When these experts have completed their missions, the only task remaining will be deciding whether to partner with BigPharma or to go it alone. Previous comments indicate a partnership.Having presented a 'fait accompli' they will be able to negotiate some very favorable terms. The world awaits and we can say that we were there at the creation.
Market Data 
Markets 
AI
